Poly Medicure Ltd — Interim / Quarterly Report 2020

Jun 23, 2020

==> picture [164 x 48] intentionally omitted <==

==> picture [168 x 94] intentionally omitted <==

E.TransactionswithRelated Party during halfyearendedon31st March 2020	E.TransactionswithRelated Party during halfyearendedon31st March 2020	(AmtRs.inLacs)From01.10.2019to31.03.2020476.56651.2610.472480.050.080.8545.4631.60303.36293.3827.084.8623.2618.761.070.180.0054.886.006.006.505.756.006.00..--=-o~JEO~.-100.49-c),,-,~~Scanned with CamScanner
ParticularsSalesofGoodsUltra forMedical Products EgyptVitromed HealthcarePurchasesofGoodsPolyMedicure LimitedJobworkVitromedHealthCareRentreceivedVitromedHealthcareRentpaidJaiPolypan Pvt. Ltd.Dividend/Governing CouncilShareReceivedUltraforMedical Products,EgyptAdvancefromAssociates		From01.10.2019to31.03.2020
		476.56
		651.26
		10.47
		2480.05
		0.08
		0.85
		45.46
UltraforMedical Products,Egypt		31.60
Directors/Key Managerial Personnels' Remuneration Including commission
Mr.Himanshu Baid		303.36
Mr.RishiBaid		293.38
Mr. J.K.Oswal		27.08
Mr. Avinash Chandra		4.86
Defined benefit obligations
Mr. Himanshu Baid		23.26
Mr.Rishi Baid		18.76
Mr. J. K. Oswal		1.07
Mr. Avinash Chandra		0.18
Share basedpayment
Mr.J. K. Oswal		0.00
**Salary **andperquisites
Mr. Vishal Baid		54.88
Commission and Sitting fees
Mr. J. K. Baid		6.00
Mrs. Mukulika Baid		6.00
Mr.DevendraRaj Mehta		6.50
Mr.Prakash Chand Surana		5.75
Mr. ShailendraRaj Mehta		6.00
_Dr. _SandeepBhargavaManagementFee		6.00
Mr. Alessa	ndro Balboni	100.49